GLENMEDE TRUST CO NA - JUNO THERAPEUTICS INC ownership

JUNO THERAPEUTICS INC's ticker is JUNO and the CUSIP is 48205A109. A total of 163 filers reported holding JUNO THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is 2.35 and the average weighting 1.3%.

Quarter-by-quarter ownership
GLENMEDE TRUST CO NA ownership history of JUNO THERAPEUTICS INC
ValueSharesWeighting
Q1 2018$7,0000.0%1560.0%0.00%
Q4 2017$7,000
+16.7%
1560.0%0.00%
Q3 2017$6,000
+200.0%
156
+4.0%
0.00%
Q4 2016$2,000
-75.0%
150
-25.0%
0.00%
Q4 2015$8,0000.0%2000.0%0.00%
Q3 2015$8,000
-20.0%
2000.0%0.00%
Q2 2015$10,000
-16.7%
2000.0%0.00%
Q1 2015$12,000
+20.0%
2000.0%0.00%
Q4 2014$10,0002000.00%
Other shareholders

There were no reported owners of JUNO THERAPEUTICS INC in Q4 2015.

NameSharesValueWeighting ↓
View complete list of JUNO THERAPEUTICS INC shareholders